Pregled bibliografske jedinice broj: 1125538
New-onset diabetes after kidney transplantation: diagnosis, risk factors, and management
New-onset diabetes after kidney transplantation: diagnosis, risk factors, and management // Acta clinica Croatica. Supplement, 60 (2021), 1; 86-95 doi:10.20471/acc.2021.60.s1.13 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1125538 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
New-onset diabetes after kidney transplantation:
diagnosis, risk factors, and management
Autori
Bulum, Tomislav ; Prkačin, Ingrid ; Duvnjak, Lea
Izvornik
Acta clinica Croatica. Supplement (0353-9474) 60
(2021), 1;
86-95
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
new-onset diabetes after transplantation (NODAT) ; immunosuppressive drugs ; diabetes management ; kidney
Sažetak
New-onset diabetes after transplantation (NODAT) is a frequent and severe complication after renal transplantation. Risk factors for NODAT are non- modifiable (non-white ethnicity, older age, genetic predisposition, previous glucose intolerance, steroid therapy, male donor, and others) and modifiable (obesity, viral infections, and immunosuppressive therapy). Glucose control is needed immediately after renal transplantation and after 3, 6, and 12 months and annual glucose control is needed after that period. Pharmacotherapy includes oral hypoglycemic agents (in most cases metformin, sulfonylureas, and dipeptidyl peptidase-4 (DPP-4) inhibitors) and insulin (in most cases biphasic insulin several times daily or intensive insulin therapy). Regular annual screening should be performed for micro- and macrovascular complications of diabetes.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Medicinski fakultet, Zagreb
